Navigation Links
Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:1/23/2008

esponses," said Steven W. King, president and CEO of Peregrine. "We are optimistic that this new trial, along with our other Phase II bavituximab breast cancer trial, will provide us with valuable insights into bavituximab's potential in this important disease. We are now proceeding with final preparations for the trial and look forward to study initiation in the near future."

Tumor response in this study will be evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) parameters. The trial is being conducted according to International Conference on Harmonization (ICH) and Good Clinical Practices (GCP) standards.

The National Cancer Institute estimates that approximately 178,480 U.S. women were diagnosed with breast cancer in 2007 and 40,460 women died of the disease. According to the World Health Organization, breast cancer is the most commonly diagnosed cancer in women, and is second only to lung cancer as a leading cause of female cancer deaths.

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is usually located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase lb trial in advanced cancer patients, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. Peregrine has now received regulatory approval for three Phase II clinical trials to study the anti-tumor effects of bavituximab in combination with chemotherapy: A breast cancer protocol in combination with docetaxel, a second breast cancer protocol in combination with carboplatin plus paclitaxel, and
'/>"/>

SOURCE Peregrine Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 The consumer ... evolving across industry sectors to better identify winning ... ways to engage with and understand consumers, as ... and make critical purchasing decisions. ... Practices, LLC, one area where organizations can observe ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
(Date:7/11/2014)... , July 11, 2014  Veran ... company, announced today the positive, cost-effective final ... innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous ... a percutaneous approach to biopsy when a ... patients and physicians experience positive financial outcomes ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Veran Medical Publishes Lung Cancer Patient Management Study 2
...   Amcor Flexibles ... million in its Singen converting plant in ... of pharmaceutical packaging,and upgrades the classic converting ...      (Logo:  http://www.newscom.com/cgi-bin/prnh/20110630/465056  ) ...
... Va., June 29, 2011 The last ten years have ... Valley, Virginia. The former Pentagon employee, who survived the 9/11 ... debilitating neurological disorder. Medications controlled his tremor for ... Williams found it impossible to do anything with his dominant ...
Cached Medicine Technology:Amcor Invests €6.7 Million in the Extension of its Singen Converting Plant in Germany 2Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound 2
(Date:7/14/2014)... (PRWEB) July 14, 2014 In ... carriers emphasized lower-cost narrow-network products, accountable care organizations ... chose coverage based on price, rather than on ... from seeking care from out-of-network providers. “Using ... Narrow Networks and Exchange Products,” the July ...
(Date:7/14/2014)... EnergyFirst, manufacturer of all-natural nutritional ... for its great products, thriving customer base, and ... its products as Jim’s Permalean Protein Powders and Jim’s ... EnergyFirst’s lineup of nutritional products. The Permalean brand will ... , Founded in 1999, Permalean’s products were designed to ...
(Date:7/14/2014)... 2014 Crystal Dental has recently ... The announcement has been made via LAD Solutions in in ... announcement has been made in order to draw in new ... Sacramento area. , Crystal Dental offers a variety of services ... offered by Crystal Dental include cosmetic dentistry procedures such as ...
(Date:7/13/2014)... St. Petersburg, FL (PRWEB) July 14, 2014 ... Fresh Citrus Scrub at Sublime Beauty®. Use coupon code ... Tuesday, July 15th. , "Everyone who tries the Fresh Citrus ... ® founder, Kathy Heshelow. "It is a perfect little cleanser ... too." , It has non-abrasive beads that help to exfoliate ...
(Date:7/13/2014)... Recently, iFitDress.com, one of the most famous dress ... of brown evening dresses for worldwide clients. ... discounted prices, up to 50% off. , All ... are carefully made according to most fashionable styles. In ... offers pretty accessories: wedding shoes, dancing shoes, sandals, boots ...
Breaking Medicine News(10 mins):Health News:Milliman, FAIR Health Executives to Discuss Data-Based Rate Setting for Out-of-Network Providers in Atlantic Information Services Webinar 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2Health News:Discover the Favorite Sublime Beauty® Citrus Scrub: Special "Two-Day Only" Sale 2Health News:2014 Brown Evening Dresses Added To iFitDress.com 2
... tooth decay has been developed by BASF, a German company, and ... The company claims its// product can reduce the amount of harmful ... developed in collaboration with another German company OrganoBalance. ... mutans (bacteria involved in tooth decay) from adhering to the tooth. ...
... a team lead by Salim Yusuf and Koon Teo at the ... increases the risk of heart attack.// ,The study ... all forms, whether smoked or chewed first hand or second hand, ... among 27,000 people in 52 countries to calculate the risk of ...
... Health Survey for Punjab is bittersweet. While Punjab has ... retain the fertility// level at two children per woman, there ... Nearly 38% women and 30% men are obese, the ... CRRID in Punjab, studied nearly 3000 households. Gopal Krishan, director ...
... to throng the Mahim beach to drink sweet seawater ... people against drinking// the polluted water. ,Scientists ... the natural phenomenon of dilution. ,"Dilution is ... India during the southwest monsoon and occurs when rainwater ...
... study has found that childhood cancer survivors are at ... was made by Christopher Recklitis and colleagues// at the ... aged 28. All patients were adult survivors of childhood ... average of 18 years after their initial cancer diagnosis. ...
... a meeting of scientists in Australia, University of Oregon ... and cephalopods showed how brain regulation// is present even ... FMRFamide-related peptides are the two brain chemicals that enable ... in just seconds. ,In a paper that ...
Cached Medicine News:Health News:Maharashtra warns against Mahim's 'miracle' water 2Health News:Brain Regulation Present Even In Spineless Creatures 2Health News:Brain Regulation Present Even In Spineless Creatures 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: